Abboticin ES 500 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

abboticin es 500 mg

amdipharm limited - erytromycinetylsuksinat - tablett, filmdrasjert - 500 mg

Aridol নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

aridol

pharmaxis europe limited - mannitol - inhalasjonspulver, hard kapsel - 20 mg / 40 mg / 10 mg / 0 mg / 5 mg

Puri-Nethol 50 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

puri-nethol 50 mg

aspen pharma trading limited - merkaptopurin - tablett - 50 mg

Zyloric 100 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

zyloric 100 mg

aspen pharma trading limited - allopurinol - tablett - 100 mg

Zyloric 300 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

zyloric 300 mg

aspen pharma trading limited - allopurinol - tablett - 300 mg

Locametz ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

locametz

novartis europharm limited  - gozetotide - radionuklide bildebehandling - diagnostiske radiopharmaceuticals - dette legemidlet er kun til diagnostisk bruk. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.

Erwinase 10000 E নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

erwinase 10000 e

porton biopharma limited - krisantaspase - pulver til injeksjons-/infusjonsvæske, oppløsning - 10000 e

Bronchitol ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

bronchitol

pharmaxis europe limited - mannitol - cystisk fibrose - hoste og kalde preparater - bronchitol er indisert for behandling av cystisk fibrose (cf) hos voksne i alderen 18 år og over som en tilleggsbehandling til den beste pasientstandarden.

Prometax ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

prometax

novartis europharm limited - rivastigmin - alzheimer disease; parkinson disease; dementia - psychoanaleptics, - symptomatisk behandling av mild til moderat alvorlig alzheimers demens. symptomatisk behandling av mild til moderat alvorlig demens hos pasienter med parkinsons sykdom.

Suboxone ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

suboxone

indivior europe limited - buprenorfin, nalokson - opioid-relaterte lidelser - andre nervesystemet narkotika - substitusjonsbehandling for opioidmisbruk, innenfor rammen av medisinsk, sosial og psykologisk behandling. intensjonen med naloxon-komponenten er å avskrekke intravenøs misbruk. behandlingen er beregnet til bruk hos voksne og ungdom over 15 år som har avtalt å bli behandlet for avhengighet.